Wise Choices in the Intensive Care Unit
Part of Kidney & urinary, Lungs & breathing, Women’s health & pregnancy clinical trials.
This study looks at how decisions are made in the ICU. It may help improve care for adult patients in Swedish intensive care units.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 years or older.
- You are being treated in a Swedish intensive care unit (ICU).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at the best timing for starting kidney support treatment (dialysis) in very sick people in the ICU. It may help improve outcomes by comparing different start times.
This study focuses on critically ill people in the intensive care unit (ICU). It aims to learn what affects outcomes and resources, which may help improve how care is planned for ICU patients.
This study talks to adults who have been in an intensive care unit (ICU) to understand their views on life-sustaining treatments, end-of-life wishes, and when they would want less or more care. It aims to improve how doctors and families make these hard decisions together.
This trial collects and studies health information from people who are critically ill and admitted to an intensive care unit. It may help doctors learn how to better care for ICU patients in the future.
This study helps families and doctors make shared decisions about starting urgent dialysis for a patient with sudden kidney failure in the ICU. It aims to improve communication and support for families during this difficult time.
This study looks at how urine output after being in the intensive care unit (ICU) can help detect early kidney problems. It may help doctors better monitor and protect kidney function in critically ill patients.
Hear when a new Critical Illness trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.